Literature DB >> 1497957

Chronic lung disease in very low birthweight infants: a prospective population-based study.

B A Darlow1, L J Horwood.   

Abstract

A prospective population-based study of chronic lung disease among all very low birthweight infants (birthweight 500-1499 g) born in New Zealand in 1986 is reported. Of 413 of these infants admitted to neonatal units, 355 (86%) survived to 28 days. An additional 50 infants were recorded as liveborn but died in the labour ward or other place of birth. Both observed survival and survival adjusted for birthweight, gestation and gender were significantly (P less than 0.05) better in larger centres. Oxygen requirement was assessed at 28 days of age, 36 weeks equivalent gestation and 84 days of age, when 38.6, 23.1 and 13.8% of infants, respectively, were being treated with oxygen. To examine the joint effects of predictor variables on oxygen requirement at each age, the data were analysed using multiple logistic regression methods. At 28 days, lower birthweight, shorter gestation, respiratory distress syndrome (all P less than 0.0001), and gender and hospital principally caring for the infant (both P less than 0.05) were significantly associated with treatment with oxygen. In comparison with other studies, New Zealand appears to have a relatively high rate of chronic lung disease. We speculate that a contributing factor may be the small size of some regional neonatal units.

Entities:  

Mesh:

Year:  1992        PMID: 1497957     DOI: 10.1111/j.1440-1754.1992.tb02672.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  7 in total

1.  Outcomes for high risk New Zealand newborn infants in 1998-1999: a population based, national study.

Authors:  A E Cust; B A Darlow; D A Donoghue
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

2.  Improved outcomes for very low birthweight infants: evidence from New Zealand national population based data.

Authors:  B A Darlow; A E Cust; D A Donoghue
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

Review 3.  Emerging Clinical Benefits of New-Generation Fat Emulsions in Preterm Neonates.

Authors:  Gregory Guthrie; Muralidhar Premkumar; Douglas G Burrin
Journal:  Nutr Clin Pract       Date:  2017-01-27       Impact factor: 3.080

4.  A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia.

Authors:  Manizheh M Gharehbaghi; Shalale Ganji; Majid Mahallei
Journal:  Oman Med J       Date:  2021-07-31

5.  Bronchopulmonary dysplasia in infants with respiratory distress syndrome in a developing country: a prospective single centre-based study.

Authors:  J Smith; S Kling; R P Gie; J van Zyl; G F Kirsten; E D Nel; J W Schneider
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

6.  Lipid peroxidation as a measure of oxygen free radical damage in the very low birthweight infant.

Authors:  T E Inder; P Graham; K Sanderson; B J Taylor
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-03       Impact factor: 5.747

7.  The efficacy of intratracheal administration of surfactant and budesonide combination in the prevention of bronchopulmonary dysplasia.

Authors:  Manizheh Mostafa Gharehbaghi; Majid Mhallei; Shalale Ganji; Sanaz Yasrebinia
Journal:  J Res Med Sci       Date:  2021-05-27       Impact factor: 1.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.